
Somata Genesis Biotech Private Limited
About Somata Genesis Biotech Private Limited
Data last updated:
Somata Genesis Biotech Private Limited is a private limited company based in Pune, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 15 January 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U74999PN2016PTC157972.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Aanchal Banerjee and Surjo Samiran Banerjee.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Lane 9B S No 53 Shivneri Nagar Kondhwa Khurdh, Pune, Maharashtra, India – 411048.
As per the financials filed for FY 2025, the company reported a revenue of ₹94.14 Lakh, a decline of 44% compared to the previous year. For the same year it recorded a net loss of ₹26.47 Lakh (net margin -28.1%) and EBITDA of -₹13.16 Lakh (EBITDA margin -14%). Revenue has grown at a compounded annual rate (CAGR) of 26% over three years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Somata Genesis Biotech Private Limited's registered office is in Pune, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered AddressLane 9B S No 53 Shivneri Nagar Kondhwa Khurdh, Pune, Maharashtra, India – 411048
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Somata Genesis Biotech Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Somata Genesis Biotech is manufacturing. In detail, this covers wood and wood products, furniture, paper and paper products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C3 | Wood and wood products, furniture, paper and paper products |
To see the full business activity and turnover split of Somata Genesis Biotech Private Limited, buy the company report.
Financials of Somata Genesis Biotech Private Limited
FY 2025 filings availableSomata Genesis Biotech Private Limited reported revenue of ₹94.14 Lakh (down 44% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 44% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 26%. EBITDA fell 472% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹13.16 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹26.47 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -14% | ||||
| Net Profit Margin | -28.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Somata Genesis Biotech Private Limited, buy the company report.
Board of directors of Somata Genesis Biotech Private Limited
Somata Genesis Biotech has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Aanchal Banerjee | Director | 15 Jan 2016 | 10 Years 10 Months | Current |
| Surjo Samiran Banerjee Also directs: Surjo Information Solutions Private Limited | Director | 15 Jan 2016 | 10 Years 10 Months | Current |
Legal cases
No court or tribunal cases involving Somata Genesis Biotech Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Somata Genesis Biotech Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Somata Genesis Biotech Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Somata Genesis Biotech Private Limited has 2 board changes on record since 2016: 2 appointments. The latest: Aanchal Banerjee was appointed as Director on 15 Jan 2016.
Frequently asked questions
Somata Genesis Biotech is an active private limited company based in Pune, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 15 January 2016 (10+ years old) and is registered under CIN U74999PN2016PTC157972.
Somata Genesis Biotech has 2 current directors:
- Aanchal Banerjee - Director
- Surjo Samiran Banerjee - Director
The latest financial statements of Somata Genesis Biotech on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2016 are in the company report.
The CIN (Corporate Identification Number) of Somata Genesis Biotech is U74999PN2016PTC157972. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Somata Genesis Biotech was incorporated on 15 January 2016, making it 10+ years old. It is registered with the Registrar of Companies, Pune.
Aanchal Banerjee was appointed as Director on 15 Jan 2016. Surjo Samiran Banerjee was appointed as Director on 15 Jan 2016.
The registered office of Somata Genesis Biotech is at Lane 9B S No 53 Shivneri Nagar Kondhwa Khurdh, Pune, Maharashtra, India – 411048.
Somata Genesis Biotech operates in the pharma industry, in the drug formulation and development segment.
The compliance status of Somata Genesis Biotech is compliant as of 09 September 2026. The company is actively filing with the Registrar of Companies.
Somata Genesis Biotech can be reached at its registered office: Lane 9B S No 53 Shivneri Nagar Kondhwa Khurdh, Pune, Maharashtra, India – 411048.

